Guided Therapeutics (GTHP) Share-based Compensation (2011 - 2025)
Guided Therapeutics recorded quarterly Share-based Compensation of $25000.0 in Q4 2025, up 65.37% quarter-over-quarter from $15118.0 in Q3 2025, and up 292.31% year-over-year from $6372.5 in Q4 2024.
Guided Therapeutics' Share-based Compensation history runs 15 years deep, the most recent figure standing at $25000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation rose 292.31% year-over-year to $25000.0; the TTM figure through Dec 2025 stood at $55518.0 (up 183.6% YoY), while the FY2025 annual figure was $377000.0, up 214.17% from the prior year.
- Share-based Compensation came in at $25000.0 for Q4 2025 at Guided Therapeutics, up from $15118.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.1 million in Q2 2023 to a low of -$821353.0 in Q4 2022.
- A 5-year average of $62996.2 and a median of $21091.5 in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation plunged 1742.71% in 2022 and jumped 2443.18% in 2023, its largest moves.
- Guided Therapeutics' Share-based Compensation stood at $50000.0 in 2021, then slumped by 1742.71% to -$821353.0 in 2022, then soared by 93.43% to -$54000.0 in 2023, then jumped by 75.93% to -$13000.0 in 2024, then soared by 292.31% to $25000.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $25000.0, $15118.0, and $15381.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 15,118.00 |
| Sep 30, 2025 | 15,118.00 |
| Jun 30, 2025 | 15,381.00 |
| Jun 30, 2025 | 15,381.00 |
| Mar 31, 2025 | 19.00 |
| Mar 31, 2025 | 19.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 16,145.00 |
| Sep 30, 2024 | 16,145.00 |
| Jun 30, 2024 | 16,401.00 |
| Jun 30, 2024 | 16,401.00 |
| Mar 31, 2024 | 30.00 |
| Mar 31, 2024 | 30.00 |
| Dec 31, 2023 | -54,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Sep 30, 2023 | 17,183.00 |
| Sep 30, 2023 | 17,183.00 |
| Jun 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 564,000.00 |
| Mar 31, 2023 | 564,000.00 |
| Dec 31, 2022 | -821,353.00 |
| Dec 31, 2022 | -821,353.00 |
| Sep 30, 2022 | 44,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 59,000.00 |
| Dec 31, 2020 | 59,000.00 |
| Sep 30, 2020 | 251,000.00 |
| Sep 30, 2020 | 251,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Dec 31, 2018 | 9,000.00 |
| Dec 31, 2018 | 9,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Jun 30, 2018 | 14,000.00 |
| Jun 30, 2018 | 14,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Dec 31, 2017 | 3,000.00 |
| Dec 31, 2017 | 3,000.00 |
| Sep 30, 2017 | 24,000.00 |
| Sep 30, 2017 | 24,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Mar 31, 2017 | 19,000.00 |
| Mar 31, 2017 | 19,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Jun 30, 2016 | 23,000.00 |
| Jun 30, 2016 | 23,000.00 |
| Mar 31, 2016 | 30,000.00 |
| Mar 31, 2016 | 30,000.00 |
| Dec 31, 2015 | 206,000.00 |
| Dec 31, 2015 | 206,000.00 |
| Sep 30, 2015 | 273,000.00 |
| Sep 30, 2015 | 273,000.00 |
| Jun 30, 2015 | 337,000.00 |
| Jun 30, 2015 | 337,000.00 |
| Mar 31, 2015 | 192,000.00 |
| Mar 31, 2015 | 192,000.00 |
| Dec 31, 2014 | 34,000.00 |
| Dec 31, 2014 | 34,000.00 |
| Sep 30, 2014 | 306,000.00 |
| Sep 30, 2014 | 306,000.00 |
| Jun 30, 2014 | 187,000.00 |
| Jun 30, 2014 | 187,000.00 |
| Mar 31, 2014 | 359,000.00 |
| Mar 31, 2014 | 359,000.00 |
| Dec 31, 2013 | 125,000.00 |
| Dec 31, 2013 | 125,000.00 |
| Sep 30, 2013 | 130,000.00 |
| Sep 30, 2013 | 130,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 430,000.00 |
| Mar 31, 2013 | 430,000.00 |
| Dec 31, 2012 | 152,000.00 |
| Dec 31, 2012 | 152,000.00 |
| Sep 30, 2012 | 143,000.00 |
| Sep 30, 2012 | 143,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 198,000.00 |
| Mar 31, 2012 | 198,000.00 |
| Dec 31, 2011 | 523,000.00 |
| Dec 31, 2011 | 523,000.00 |
| Sep 30, 2011 | 96,000.00 |
| Sep 30, 2011 | 96,000.00 |
| Jun 30, 2011 | 109,000.00 |
| Jun 30, 2011 | 109,000.00 |
| Mar 31, 2011 | 142,000.00 |
| Mar 31, 2011 | 142,000.00 |